Preserving The Public Trust
When you donate to OCRA, you can be sure your money is handled responsibly. By ensuring rigorous accountability, financial transparency, and meticulous stewardship of our donors’ funds, OCRA has earned the highest possible rating from Charity Navigator and a Gold rating from Guidestar. We also meet the stringent Standards for Charity Accountability set forth by the Better Business Bureau’s Wise Giving Alliance.
Please explore this page to view our financial statements and policies.
Ovarian Cancer Research Alliance is a 501(c) 3 non profit organization. Our financial documents are public and available for viewing below.
A 501(c)(3) organization, Ovarian Cancer Research Alliance receives funding from individual donors, foundations, corporations, and cause-marketing initiatives. Individual solicitations, direct mail, fundraising events, grant proposals, sponsorships, product sales, and special projects secure these funds.
Our mission is to remain objective in providing information to the ovarian cancer community; we do not endorse any particular treatment, therapy, clinical trial or product.
Ovarian Cancer Research Alliance is committed to:
Live webinar on March 25 will explore gynecologic clear cell carcinoma research, treatment, and survivorship Ovarian Cancer Research Alliance (OCRA) invites you to join our upcoming Ask the Experts webinar focused on gynecologic clear cell carcinoma, a rare subtype of gynecologic cancer. This live, interactive session will feature gynecologic oncologist Aaron Praiss, MD, who will discuss current research, treatment … Continued
This article was updated in February 2026 to reflect NCCN’s release of the 2026 Guidelines for Cervical Cancer Patients. OCRA is a proud sponsor of the 2026 Patient Guidelines for Cervical Cancer, and the 2025 Patient Guidelines for Ovarian, and Uterine Cancer. We believe ensuring access to clear, understandable information is critical. NCCN provides wonderful … Continued
$1 million global research award, plus an additional $1 million in compute support, advances AI-driven efforts to personalize ovarian cancer care The Global Ovarian Cancer Research Consortium today awarded its inaugural AI Accelerator Grant to an international team of researchers to examine whether artificial intelligence (AI) can improve how survival and treatment response are predicted … Continued
Get email updates about research news, action alerts, and ways to join the fight.
